Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Protalix Biotherapeutics Inc (PLX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Protalix historical data, for real-time data please try another search
732 +0    +0.00%
20/03 - Closed. Currency in ILS ( Disclaimer )
Type:  Equity
Market:  Israel
ISIN:  US74365A3095 
S/N:  1120609
  • Volume: 0
  • Bid/Ask: 733 / 736
  • Day's Range: 703 - 739
Protalix 732 +0 +0.00%

PLX Recent Sentiments

 
This page contains information on users’ sentiments for the Protalix Biotherapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Apr 30, 2023 Sharon Shwartz   732 Nov 30, 2023 @ 732 0.00%
Mar 23, 2023 Ran Veber   732 Apr 13, 2023 @ 732 0.00%
Mar 12, 2023 שוק ההון   649 Apr 06, 2023 @ 732 -12.79%
Mar 06, 2023 אסף חן   745 Mar 30, 2023 @ 732 -1.74%
Feb 21, 2023 Moshe Tvig   590 Mar 16, 2023 @ 733 +24.24%
Feb 16, 2023 אהוד לוי   562 Mar 09, 2023 @ 770 -37.01%
Feb 16, 2023 Ran Veber   569 Mar 09, 2023 @ 770 +35.33%
Jan 24, 2023 יוסי אלצטר   460 Feb 16, 2023 @ 570 +23.91%
Jan 19, 2023 Ran Veber   569 Feb 09, 2023 @ 554 +2.64%
Jan 19, 2023 אסף חן   568 Feb 09, 2023 @ 554 -2.46%
Dec 21, 2022 Moshe Prepelitsky   447 Jan 12, 2023 @ 544 +21.70%
Dec 12, 2022 Moshe Tvig   407 Jan 05, 2023 @ 495 +21.62%
Nov 24, 2022 אורי דרור   396 Nov 28, 2022 @ 395 +0.25%
Oct 11, 2022 Moshe Tvig   366 Nov 03, 2022 @ 368 +0.55%
Aug 25, 2022 רו ron   379 Sep 15, 2022 @ 370 -2.37%
Aug 16, 2022 נתנאל יוסף   415 Sep 08, 2022 @ 359 +13.49%
Jul 07, 2022 אסף חן   393 Jul 28, 2022 @ 366 -6.87%
Jul 07, 2022 Moshe Tvig   393 Jul 28, 2022 @ 366 -6.87%
Jun 28, 2022 רו ron   379 Jul 21, 2022 @ 376 -0.79%
Jun 22, 2022 אבי סכטר   382 Jul 14, 2022 @ 373 -2.36%
Jun 19, 2022 גל רז   375 Jul 14, 2022 @ 373 -0.53%
Jun 07, 2022 אהוד לוי   382 Jun 30, 2022 @ 366 -4.19%
Jun 01, 2022 Moshe Tvig   397 Jun 23, 2022 @ 373 -6.05%
May 09, 2022 אהוד לוי   370 Jun 02, 2022 @ 396 +7.03%
Apr 27, 2022 Moshe Tvig   372 May 19, 2022 @ 368 -1.08%
Apr 12, 2022 Eliran Elimelech   456 May 05, 2022 @ 385 +15.57%
Apr 12, 2022 itay tuka   453 May 05, 2022 @ 385 +15.01%
Apr 07, 2022 Moti Dagan   499 Apr 28, 2022 @ 374 -25.05%
Apr 05, 2022 shiri ben gal   453 Apr 28, 2022 @ 374 -17.44%
Apr 05, 2022 יוסי אלצטר   460 Apr 28, 2022 @ 374 -18.70%
Apr 05, 2022 רו ron   509 Apr 28, 2022 @ 374 -26.52%
Apr 05, 2022 אורי יהודה   572 Apr 05, 2022 @ 451 -21.15%
Apr 04, 2022 גבריאל מלול   488 Apr 28, 2022 @ 374 +23.36%
Apr 04, 2022 Sigal Goldman   480 Apr 28, 2022 @ 374 -22.08%
Mar 28, 2022 ron an   375 Apr 21, 2022 @ 442 +17.87%
Mar 23, 2022 Moshe Tvig   363 Apr 21, 2022 @ 442 +21.76%
Mar 20, 2022 עמוס מליחי   331 Apr 21, 2022 @ 442 -33.53%
Mar 01, 2022 Lior Saad   273 Mar 24, 2022 @ 371 +35.90%
Feb 10, 2022 ???? ???   322 Feb 13, 2022 @ 296 -8.07%
Feb 08, 2022 משה שחר   370 Mar 03, 2022 @ 282 -23.78%
Feb 06, 2022 Moshe Prepelitsky   331 Feb 08, 2022 @ 367 +10.88%
Feb 06, 2022 רו ron   331 Mar 03, 2022 @ 282 -14.80%
Feb 06, 2022 Moshe Tvig   327 Mar 03, 2022 @ 282 -13.76%
Jan 23, 2022 Ran Veber   259 Feb 17, 2022 @ 287 -10.81%
Jan 04, 2022 אילן קרויטורו   266 Jan 27, 2022 @ 262 +1.50%
Jan 02, 2022 Uzi Nissim   263 Jan 27, 2022 @ 262 -0.38%
Dec 29, 2021 Ran Veber   272 Jan 20, 2022 @ 265 -2.57%
Dec 27, 2021 Moshe Prepelitsky   292 Jan 20, 2022 @ 265 -9.25%
Dec 26, 2021 Moshe Tvig   295 Jan 20, 2022 @ 265 -10.17%
Dec 16, 2021 שלמה רחום   271 Jan 06, 2022 @ 275 -1.48%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PLX Comments

Write your thoughts about Protalix Biotherapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
דודו רון
דודו רון Aug 02, 2023 2:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Earnings up or down any of ideas?
דודו רון
דודו רון Jan 06, 2023 7:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fda approve soon hope
SS SS
SS SS Feb 10, 2022 12:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone knows what was reported at 8th simposium? no news on internet, but stock fell 9% so I am wondering and worried a bit..
MIKHAIL KUZNETSOV
MIKHAIL KUZNETSOV Feb 01, 2022 7:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Added at 0,88
Kalzhigit Esmahan
Kalzhigit Esmahan Feb 01, 2022 7:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
right decision!!!
דודו רון
דודו רון Jan 24, 2022 11:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good sign closed Green!
דודו רון
דודו רון Nov 25, 2021 2:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bottom!?
mick ninja
mick ninja Sep 14, 2021 10:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
chapter 7
En Game
En Game Sep 10, 2021 8:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you know what f it, It was a fun ride I'm out witha small gain, cheers
דודו רון
דודו רון Sep 08, 2021 12:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Volume rising.. Any news?
Kalzhigit Esmahan
Kalzhigit Esmahan Aug 29, 2021 11:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
after September 9, is there any chance to get FDA approval?
raw disclosure
raw disclosure Aug 29, 2021 11:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
no reson why not.The only issue was the FDA not being able to inspect the manufacturing site due to covid.Protalix will eat a 4 billion dollar market
mick ninja
mick ninja Aug 29, 2021 11:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hahahahahahaahhahhahaha
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email